The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft Guideline for Post-market and market surveillance of medical device:Management of adverse events 2026 for your review and feedback. Please refer to the link: https://docs.google.com/document/d/1tZtzajFTfrsAAhFEu1R20t7OLMvyB9vtVwH73XvAi8s/edit?usp=sharing
We kindly request you to provide your comments, suggestions, or recommendations directly within the document where “commentary access” has been granted. Please refer to the link to access the draft guideline. We would appreciate receiving your inputs by 20 May 2026.
We highly appreciate your valuable inputs. Thank you.